• FDA halts Bellicum trial over brain disease in participants, shares crash 48% pharmafile
    February 02, 2018
    Texas-based clinical-stage company Bellicum Pharmaceuticals has taken a massive stock hit after the FDA put a hold on its trials of its T-cell therapy BPX-501 due to three cases of encephalopathy in participants that are thought to be treatment-related.
  • NHL Veterans Pledge Their Brains to Research drugs.com
    February 24, 2017
    Several former National Hockey League players have joined the growing number of pro athletes who have pledged their brains to research on chronic traumatic encephalopathy (CTE) -- a devastating brain disease that has been linked to repetitive head trauma.
PharmaSources Customer Service